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Abstract: γ-Glutamyl-cysteinyl-glycine (GSH) plays a critical role in maintaining redox homeostasis
in biological systems and a decrease in its cellular levels is associated with diseases. Existing
fluorescence-based chemosensors for GSH acts as irreversible reaction-based probes that exhibit
a maximum fluorescence (‘turn-on’) once the reaction is complete, regardless of the actual
concentration of GSH. A reversible, reaction-based ‘turn-off’ probe (1) is reported here to sense
the decreasing levels of GSH, a situation known to occur at the onset of various diseases. The more
fluorescent merocyanine (MC) isomer of 1 exists in aqueous solution and this reacts with GSH
to induce formation of the ring-closed spiropyran (SP) isomer, with a measurable decrease in
absorbance and fluorescence (‘turn-off’). Sensor 1 has good aqueous solubility and shows an
excellent selectivity for GSH over other biologically relevant metal ions and aminothiol analytes.
The sensor permeates HEK 293 cells and an increase in fluorescence is observed on adding buthionine
sulfoximine, an inhibitor of GSH synthesis.
Keywords: reversible sensor; photoswitch; spiropyran; fluorescent sensor; reduced glutathione;
intracellular sensing; turn-off sensor
1. Introduction
γ-Glutamyl-cysteinyl-glycine (GSH) is the most abundant thiol in biological systems [1,2], with a
central role in critical cellular functions including redox regulation and cellular signalling [3–7].
Current strategies for its sensing include high performance liquid chromatography [8], gas
chromatography-mass spectrometry [9], electro-chemical assays [10], and spectroscopic detection
using fluorescent chemosensors [11–13]. Typical fluorescent ‘turn on’ chemosensors function as
reaction-based probes, binding to GSH irreversibly with a high sensitivity and selectivity [14,15]. Here,
an increase in GSH levels is accompanied by an increase in fluorescence [16,17]. This is fine for healthy
cells that possess base-line millimolar concentrations of GSH [18]. However, many diseases including
Parkinson’s [19,20], cancer [21,22], heart diseases [23], and Alzheimer’s [24] are indicated by a decrease
in GSH levels. In this case, a ‘turn on’ sensor would result in reduced fluorescence relative to healthy
cells. An important advance would come from the development of a sensor that is measurably turned
off by GSH, and back on by a lower level of GSH. This would then provide an opportunity to sense
reduced GSH levels during the onset of important diseases [25].
A spiropyran-based ‘turn-on’ sensor that selectively and reversibly detects GSH in cells has
been recently reported [26,27]. This sensor contains two spiropyran units linked by an unsubstituted
piperazine, and exists as the ring closed spiropyran isomer (SP) in solution. Exposure to GSH switches
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the sensor on through formation of the fluorescent merocyanine (MC) isomer, which is proposed to
bind non-covalently to GSH [26]. The sensor shows excellent selectivity for GSH over other intracellular
thiol-containing species [26]. Multiple measurements on a single sample are possible without the need
to change the sensor [28,29]. Here, we report a new reversible ‘turn-off’ spiropyran-based GSH sensor
(1, Figure 1) where the fluorescence and absorbance are inversely proportional to the level of GSH.
The sensor has good water solubility and biocompatibility and is suitable for intracellular sensing.
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mass spectra were collected using an LTQ Orbitrap XL ETD using flow injection, with a flow rate of 
5 μL/min. Where indicated compounds were analyzed and purified by reverse phase HPLC, using 
an HP 1100 LC system equipped with a Phenomenex C-18 column (250 × 4.6 mm) for analytical 
traces and a Gilson GX-Prep HPLC system equipped with a Phenomenex C18 column  
(250 × 21.2 mm). H2O and MeCN solutions were used as aqueous and organic buffers. All 
absorbance and fluorescence spectra were collected on a Synergy H4 Hybrid Multimode Microplate 
Reader using black-walled clear bottom 96-well plates. Data was processed using Microsoft Excel 
2016 and all graphs were generated using GraphPad Prism 7 software. A mercury lamp (365 nm) 
was used as the UV light source in photoswitching experiments. 
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To a solution of compound 2a (250 mg, 1.16 mmol) in anhydrous THF (25 mL) was added
compound 3 (66 mg, 0.58 mmol) in one portion. The mixture was stirred under N2 while triethylamine
(234 mg, 2.32 mmol) was added dropwise. The reaction mixture was heated to reflux for 18 h under
N2. The mixture was cooled to r.t. and the precipitate was collected and washed with MeOH (5 mL)
under vacuum to yield the compound 4a as a yellow solid (254 mg, 93%). 1H-NMR (500 MHz,
DMSO-d6) δ 10.25 (s, 2H), 7.37 (d, J = 8.8 Hz, 2H), 7.29 (d, J = 8.8 Hz, 2H), 4.26 (d, J = 15.0 Hz, 2H),
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3.46 (d, J = 15.0 Hz, 2H), 2.84 (d, J = 10.7 Hz, 2H), 2.58 (br s, 2H), 2.17 (t, J = 11.1 Hz, 2H), 1.78–1.72
(m, 2H), 1.08 (d, J = 6.3 Hz, 6H). 13C-NMR (126 MHz, DMSO-d6) δ 193.3, 160.5, 158.9, 157.1, 130.6, 125.6,
114.9, 70.1, 58.8, 56.8, 28.2. HRMS (ESI) found [M + H]+ 473.1663, C22H25N4O8+ requires 473.1672.
2.2.2. 3,3′-(((2S,5R)-2,5-Dimethylpiperazine-1,4-diyl)bis(methylene))bis(2-hydroxy-5-
methylbenzaldehyde) (4b)
To a solution of compound 2b (485 mg, 2.63 mmol) in anhydrous THF (10 mL) was added to
compound 3 (150 mg, 1.32 mmol) in one portion. The mixture was stirred under N2 while triethylamine
(530 mg, 5.25 mmol) was added dropwise. The reaction mixture was heated to reflux for 18 h under
N2. The mixture was cooled to r.t. and the volatiles were removed in vacuo. The crude mixture
was purified by flash column chromatography (DCM:MeOH 98:2) to yield the compound 4b as a
yellow solid (200 mg, 37%). 1H-NMR (500 MHz, CDCl3) δ 10.25 (s, 1H), 7.43 (s, 1H), 7.17 (s, 1H), 4.29
(d, J = 14.1 Hz, 1H), 3.25 (d, J = 14.1 Hz, 1H), 2.86 (d, J = 12.0 Hz, 1H), 2.58 (br s, 1H), 2.31 (s, 3H), 2.13
(t, J = 11.1 Hz, 1H), 1.17 (d, J = 6.2 Hz, 3H). 13C-NMR (126 MHz, CDCl3) δ 190.4, 156.9, 134.7, 127.2,




To a solution of compound 4a (100 mg, 0.21 mmol) in anhydrous MeCN (6 mL) was added to
compound 5 [31] (115 mg, 0.53 mmol) and piperidine (49 mg, 0.57 mmol). The mixture was heated to
reflux for 18 h under N2. The mixture was cooled to r.t. and the precipitate was washed with MeCN
(5 mL) and collected by vacuum filtration. This was then purified by reverse-phase HPLC to give
compound 1 as a pale brown solid (32 mg, 18%). 1H-NMR (500 MHz, DMSO-d6) δ 8.28–8.07 (m, 2H),
8.02–7.89 (m, 2H), 7.80–7.74 (m, 2H), 7.69 (d, J = 5.7 Hz, 2H), 7.25 (d, J = 10.8 Hz, 2H), 6.69–6.55 (m, 2H),
6.01 (d, J = 10.3 Hz, 2H), 3.74–3.58 (m, 2H), 2.82–2.70 (m, 2H), 2.68 (d, J = 15.4 Hz, 6H), 2.29–2.13
(m, 2H), 1.96–1.86 (m, 2H), 1.57–1.45 (m, 2H), 1.26 (s, 6H), 1.15 (s, 6H), 0.46–0.33 (m, 6H). 13C-NMR
(126 MHz, DMSO-d6) δ 167.9, 155.4, 151.6, 140.9, 136.4, 131.3, 130.1, 129.0, 123.3, 122.8, 122.1, 121.6,




To a solution of compound 4b (100 mg, 0.21 mmol) in anhydrous EtOH (6 mL) was added
to compound 5 [31] (115 mg, 0.53 mmol) and triethylamine (58 mg, 0.57 mmol). The mixture was
heated to reflux for 18 h under N2. The mixture was cooled to r.t. and the solvent was removed in
vacuo and the resultant crude mixture was purified by reverse-phase HPLC to give compound 6 as
a brown solid (24 mg, 14%). 1H-NMR (500 MHz, DMSO-d6) δ 7.74 (d, J = 8.2 Hz, 1H), 7.64 (s, 1H),
6.97 (d, J = 10.1 Hz, 1H), 6.88 (d, J = 8.2 Hz, 1H), 6.80 (s, 1H), 6.60–6.37 (m, 1H), 5.75 (d, J = 10.1 Hz,
1H), 3.68 (d, J = 12.5 Hz, 1H), 3.56 (d, J = 12.5 Hz, 1H), 2.65 (s, 3H), 2.60 (d, J = 7.6 Hz, 1H), 2.19 (s, 3H),
1.95–1.67 (m, 1H), 1.47–1.29 (m, 1H), 1.24 (s, 3H), 1.11 (d, J = 9.6 Hz, 3H), 0.35 (s, 3H). 13C-NMR
(151 MHz, DMSO-d6) δ 170.5, 154.0, 153.3, 139.2, 136.9, 133.9, 132.8, 132.4, 126.0, 124.3, 122.0, 121.8,
118.0, 108.8, 107.8, 75.4, 63.3, 56.2, 54.6, 53.8, 31.5, 28.6, 25.4, 23.9, 22.9. HRMS (ESI) found [M + H]+
809.4299, C50H57N4O6+ requires 809.4278.
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2.3. Spectroscopic Analyses of Sensors 1 and 6
2.3.1. Absorbance
Sensors 1 (1 mM) and 6 (1 mM) were dissolved in 0.1% DMSO/water for 1, 2% DMSO/water for
6 and in 100% acetonitrile separately. The samples were left in the dark at an ambient temperature for
30 min. Absorbance of each sample was measured on the plate reader (λ = 300–700 nm).
Sensor 1 (1 mM) was then mixed with GSH (5 mM) and the absorbance was similarly measured.
This mixture was then incubated in the dark overnight with the absorbance measured again.
The experiments were carried out in triplicate.
2.3.2. In-Solution Photoswitching of Sensor 1 in the Presence and Absence of GSH
A solution of 1 in 0.1% DMSO in water (50 µM, 100 µL) was incubated at an ambient temperature
for 30 min. UV-Vis absorption (λ = 300–700 nm) of this sample was measured on the plate reader.
The sample was mixed with GSH (5 mM) and incubated for 30 min at an ambient temperature followed
by the measurement of UV-Vis absorption. This mixture was then exposed to UV light (365 nm) for
10 min, incubated in the dark for 30 min and re-exposed to UV irradiation for 10 min with UV-Vis
absorption measured immediately after each step. The experiment was carried out in triplicate in
the dark.
2.3.3. Determining the Rate Constant and Half-Life of Sensor 1 upon Reaction with GSH
Sensor 1 (50 µM) in 0.1% DMSO in water was incubated at an ambient temperature for 30 min.
UV-Vis absorption (λ = 300–700 nm) of this sample was measured on the plate reader. The sample
was then mixed with GSH (5 mM) and the absorption of the sample was measured immediately after
mixing. The absorption of this sample was monitored continuously for the next 120 s with an interval
of 2 s between each read. The values were normalised to the absorbance of the sample without GSH
using Microsoft Excel and plotted against time (s) in GraphPad Prism 7.0. A single exponential decay
curve was fitted to the plot to extrapolate Kobs and t1/2.
2.3.4. Fluorescence of Sensor 1 and 6 with Increasing Concentrations of GSH
Sensors 1 and 6 (50 µM) were separately incubated in 0.1% DMSO in water for 30 min at an
ambient temperature. The solutions were then separately mixed with varying GSH concentrations
([GSH] = 0–5 mM). All concentrations of sensors 1 and 6 and GSH reported are final concentrations of
the solution after mixing. The resultant fluorescence (λex = 532 nm) spectra of 1 of each concentration
of GSH was recorded on the plate reader (Figure S3A). Fluorescence was similarly measured for 6 with
λex = 478 nm (Figure S3B). The experiments were carried out in triplicate in the dark. The fluorescence
intensities at 650 nm in Figure S3A were plotted against a log of GSH concentration in M to produce
a standard curve of calibration for sensor 1. A linear trendline was fitted to the plot by GraphPad
Prism 7.0.
2.3.5. Quantum Yield Calculation
In a 96-well plate, the UV-vis absorbance and fluorescence spectra (λex = 512 nm) of the solvent
background (water for Rhodamine B, 0.1% DMSO for 1) were recorded. This was repeated for five
solutions with increasing concentration of 1 (25, 50, 75, 150, 250 µM) at excitation wavelength of 512 nm.
This was repeated for Rhodamine B with concentrations of 0.1, 0.2, 0.5, 1, and 2 µM. The experiment
was carried out in duplicate. A graph of integrated fluorescence vs. absorbance (Figure S4) was
obtained. Quantum yield was calculated using the following equation:
Φx = ΦST (Gradx/GradST)(η2x/η2ST)
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where subscripts ST and x denote standard (Rhodamine B) and 1, respectively, Φ is fluorescence
quantum yield, Grad is the gradient from the plot of integrated fluorescence intensity vs. absorbance
and η is the refractive index of the solvent (0.1% DMSO in water = 1.3542 [32], water = 1.3332 [32]).
The fluorescence quantum yield of rhodamine B in water at λex = 512 nm is 0.3 as reported
in literature [33].
2.3.6. Selectivity of Sensor 1
In a black 96-well plate, sensor 1 (50 µM) was separately mixed with solutions (1 mM) of various
competing substrates (GSSG/Cys/Glu/Asp/2-mercaptaethanol/Ca2+/Zn2+/Na+/K+) in 0.1% DMSO
in H2O. The mixtures were incubated in the dark for 30 min before fluorescence spectra (λex = 532 nm)
of each mixture was measured on the plate reader. Premixed samples containing 1 (50 µM), a competing
substrate (1 mM), and GSH (5 mM) were incubated in the dark at an ambient temperature for 30 min.
Fluorescence spectra of each sample was similarly measured. The experiments were carried out
in duplicate.
2.4. Cell-Based Experiments
2.4.1. Cell Viability Assay
Chemical toxicity was quantified using the AlamarBlue assay (Molecular Probes, Eugene, OR,
USA), as previously described [34]. HEK293T cells were plated a 1 × 104 cells/well in 96-well
plates, and the fluorescence were measured with a FLUOstar Optima microplate reader (BMG Labtech,
Ortenberg, Germany) after 21 h of incubation with sensor 1 (50 µM) to obtain the quantitative measures
of cell viability. Cells were incubated with HgCl (25 µM) for 1 h to generate the positive control
for cytotoxicity.
2.4.2. Confocal Cell Imaging
HEK293T cells were cultured in DMEM medium (Thermo Fisher, Waltham, MA, USA)
containing 10% heat inactivated fetal bovine serum (FBS) (Thermo Fisher, Waltham, MA, USA),
1% penicillin-streptomycin (Sigma, St. Louis, MO, USA), 1% L-glutamine (Thermo Fisher, Waltham,
MA, USA), and 2‰ fungizone (Thermo Fisher, Waltham, MA, USA). Cells were plated at
2.7 × 105 cells/mL density in 8 well ibidi-slide (ibidi, Planegg, Germany). Cell were incubated for
4 h in medium with or without 10 mM buthionine sulphoximine (BSO, Sigma, St. Louis, MO, USA).
Cells were incubated for 15 min in PBS containing 50 µM sensor 1, then washed 3 times using warm PBS
saline. Plates were exposured under a UV lamp for 10 min to activate 1 prior to imaging. An Olympus
FluroView V10i confocal microscope was used for all the imaging. For the imaging of cells treated with
GSH sensor, λAbs/λEm = 559/570–670 nm was used. Same laser intensities and reading sensitivities
were used for all imaging sessions. Cell images were processed and the overall fluorescence intensity
of each sample was measured using ImageJ Fiji.
3. Results and Discussion
3.1. Design and Synthesis of Sensor 1
Sensor 1 is somewhat unique amongst spiropyrans in that it exists predominantly as the more
fluorescent MC isomer in an aqueous environment. Fluorescence is ‘turned-off’ on reaction with GSH
with formation of the SP isomer, which has significantly weaker fluorescence (see Figure 1, 1-SP).
Sensor 1 would be expected to exist in its ‘off state’ in the presence of millimolar concentrations of
GSH, as found in healthy cells. Reduced GSH levels would then shift the equilibrium to the MC isomer
(Figure 1, 1-MC), resulting in a higher fluorescence and detection.
A 6-nitro substituent was incorporated onto the component spiropyrans of 1 to promote the
formation of the MC isomer under aqueous conditions [30,35]. In addition, a more sterically demanding
Biosensors 2017, 7, 36 6 of 13
dimethyl-piperazine core was incorporated into the design to suppress non-covalent binding of GSH
to the MC isomer as was proposed for the literature spiropyran-based ‘turn on’ sensor [26]. Finally,
a 5′-carboxylate group was introduced to enhance hydrophilicity to further improve aqueous solubility
and compatibility over the earlier sensor [28].
The synthesis of sensor 1 is outlined in Figure 2. Briefly, base-catalyzed Mannich-type reaction
of hydroxybenzaldehyde 2a with trans-2,5-dimethylpiperazine (3) gave the key bis-adduct 4a
in approximately 93% yield. Subsequent piperidine-catalyzed condensation of 4a withindolenine 5
gave 1 that was purified by C18 reverse phase HPLC. The methyl analogue of 1 (compound 6) was
similarly synthesised using starting materials 4b and 5.
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showed no such absorption peak, a result consistent with the ring-closed and less colored SP isomer in
this case. This is a critical finding for a ‘turn-off’ sensor, where the ring-opened fluorescent MC isomer
must predominate in the absence of analyte (GSH) in a polar protic solvent system. Interestingly an
analog of 1, with methyl groups in place of the nitro groups, existed predominantly as the SP isomer
in both aqueous and acetonitrile solvent systems, as seen in SI Figure S1.
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single exponential decay (‘turn-off’) to give an observed rate constant of 0.38 s−1 and half-life of 1.8 s 
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The time-dependent absorbance decay of sensor 1 in the presence of excess GSH was measured at
room temperature in 0.1% DMSO/water to approximate the reaction rate for this reaction. The decrease
in absorbance peak of the MC isomer (512–520 nm) was measured at 2 s intervals upon addition of GSH,
and the results are shown in Figure 5B. The reaction is well approximated by a single exponential decay
(‘turn-off’) to give an observed rate constant of 0.38 s−1 and half-life of 1.8 s (Figure 5B). The reaction
was complete in under 5 s, a result compatible with live-cell imaging of GSH dynamics that require
a temporal resolution of seconds. Further work is required to fully characterize the kinetics of the
reaction, but it is important to note that the observed reaction rate between sensor 1 and GSH is within
the time-scale of recently reported GSH ‘turn-on’ sensors [13,37,38].
Biosensors 2017, 7, 36  8 of 13 
GSH dynamics that require a temporal resolution of seconds. Further work is required to fully 
characterize the kinetics of the reaction, but it is important to note that the observed reaction rate 
between sensor 1 and GSH is within the time-scale of recently reported GSH ‘turn-on’ sensors 
[13,37,38].  
 
Figure 5. (A) Reversibility of sensor 1 (50 μM) at λ = 550 nm: Sensing cycle (1) Represents absorbance 
of sensor 1 in the absence of GSH; (2) and (4) represents the absorbance readings after addition of 5 
mM GSH and sensing cycles (3) and (5) represent absorbance readings after exposure of  
sensor 1 + GSH (5 mM) to UV irradiation (λ = 365 nm) for 10 min; (B) Time-dependent absorbance 
decay curve of sensor 1 after the addition of GSH (5 mM, final concentration) in 0.1% DMSO in 
water. Recording interval: 2 s. Curve (R2 = 0.9996) obtained using GraphPad Prism 7.0 (one-phase 
decay). Insert shows the observed rate constant (Kobs) and calculated half-time (t1/2).  
The fluorescence of sensor 1 in the presence of GSH was also investigated to further extend its 
sensing capabilities, e.g., for application in live-cell imaging using confocal microscopy. An aqueous 
solution of sensor 1, in the absence of GSH, gave a fluorescence emission maximum at 
approximately ~655 nm (λex = 532 nm) which is consistent with the MC isomer based on the earlier 
studies (Figure S2A). This fluorescence then decreases linearly with increasing GSH concentrations 
as shown in Figure 6. Importantly, fluorescence emission for the 6-methyl analogue of 1 mentioned 
above was not observed in either the presence or the absence of excess GSH (Figure S2B). This 
compound exists as the SP isomer and clear does not react with GSH, as per the earlier absorbance 
results. The quantum yield of 1, in the absence of GSH (0.1% DMSO in water), was determined to be 
0.029 using rhodamine B as the calibration standard as detailed in the SI, Figure S3. This result is 
comparable to the previously reported spiropyran-based sensors [39,40].  
 
Figure 6. Fluorescence of sensor 1 (final concentration 50 μM) in the presence of GSH. Maximum 
fluorescence intensities of 1 (λem = 650 nm) in the presence of increasing concentration (0–5 mM) of 
GSH was plotted against the log of GSH concentrations in M. 
Figure 5. (A) Reversibility of sensor 1 (50 µM) at λ = 550 nm: Sensing cycle (1) Represents absorbance
of sensor 1 in the absence of GSH; (2) and (4) represents the absorbance readings after addition of
5 mM GSH and sensing cycles (3) and (5) represent absorbance readings after exposure of sensor
1 + GSH (5 mM) to UV irradiation (λ = 365 nm) for 10 min; (B) Time-dependent absorbance decay curve
of sensor 1 after the addition of GSH (5 mM, final concentration) in 0.1% DMSO in water. Recording
interval: 2 s. Curve (R2 = 0.9996) obtained using GraphPad Prism 7.0 (one-phase decay). Insert shows
the observed rate constant (Kobs) and calculated half-time (t1/2).
e fl resce ce f se s r 1 i t e rese ce f S as als i esti ate t f rt er exte its
se si ca a ilities, e. ., f r a licati i li e-cell i a i si c f cal icr sc . a e s
s l ti of sensor 1, in the absence of GSH, gave a fluorescence emissio maxi um at approximately
~655 nm (λex = 532 nm) which is consistent wit the MC isomer based on the earlier studies (Figure S2A).
This fluorescence then decreases linearly with increasing GSH concentrations as shown in Figure 6.
Importa tly, fluorescence emission for the 6-methyl analogue of 1 mentioned above was not observe
in either the presence or the absence of excess GSH (Figure S2B). This compound exists as the SP
iso er a clear does not react with GSH, as per the earlier absorbance results. The quantum yield
of 1, in the absence of GSH (0.1% DMSO in water), was determined to be 0.029 using rhodamine B as
the calibration st ndard as detailed in the SI, Figure S3. This result is comparable to the previously
reported spir pyran-based sensors [39,40].
Next, sensor 1 was assayed against a range of biologically relevant metal ions (Na+, K+, Ca2+,
Zn2+), amino acids (Cys, Asp, Glu), glutathione disulfide (GSSG), and 2-mecaptoethanol (BME) to
define its selectivity profile. The sensor clearly shows good selectivity for GSH, with only GSSG and
BME showing any (weak) affinity (see Figure 7, black bars). Similar selectivity has been reported for
other mechanism-based GSH sensors [15,37]. Interestingly, sensor 1 displayed an excellent selectivity
for GSH over GSSG. The sensor also has a reduced affinity for BME. In both cases this may reflect
reduced nucleophilicity [41,42]. To our delight, the sensor showed no affinity toward cysteine,
an observation consistent with other reported GSH mechanistic sensors [11,13,37]. Competition assays
were also carried out to determine the selectivity of sensor 1 for GSH in the presence of a competing
analyte. In a 96-well plate, separate solutions of sensor 1 and GSH (5 mM) were incubated with each
Biosensors 2017, 7, 36 9 of 13
of the abovementioned analytes for 30 min, and the resulting fluorescence emission was recorded.
The results shown in Figure 7 (see grey bars) clearly show that sensor 1 has excellent selectivity for
GSH over other biologically related analytes in co-solution.
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Figure 7. Bar graph showing fluorescence of 1 (50 µM) in the presence of a range of biologically relevant
substrates: 1. blank; 2. glutathione disulfide (GSSG); 3. Cys; 4. Asp; 5. Glu; 6. 2-mecaptoethanol (BME);
7. Na+; 8. K+; 9. Ca2+; 10. Zn2+. Bars represent the fluorescence response with added GSH and/or
substrates (F) over the response in the absence of added substrate and GSH (F0). Black bars represent
samples in the absence of GSH and with added competing substrate; grey bars represent samples with
both competing substrate and GSH. Excitation wavelength = 532 nm, emission wavelength = 650 n .
3.3. Sensing of Intracellular GSH Using Sensor 1
Finally, the ability of sensor 1 to detect different levels of intracellular GSH was examined
in HEK293 cells, a good model for this experiment as the cell line has been extensively used in previous
sensing studies [43–47]. HEK293 cells were treated with a potent and specific inhibitor of glutathione
synthesis (buthionine sulphoximine, BSO) for 4 h33 to lower intracellular levels of GSH. Treated
and untreated cells were then separately incubated with sensor 1 for 15 min, with final imaging on a
confocal fluorescence microscope using the green laser for excitation. The resulting fluorescence images
(Figure 8B,D and Figure 9) reveal stronger red fluorescence within the BSO treated cells characteristics
of the MC isomer (see Figure 1). Such red fluorescence is advantageous for biological imaging since
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auto-fluorescence and scattering within tissues is minimal at these longer wavelengths. Incubating the
cells with sensor 1 (50 µM) for 21 h at 37 ◦C, an incubation time that exceeds the required experimental
time, revealed in that sensor 1 had no effect on the cell viability and is non-toxic under the experimental
conditions (See SI, Figure S4). The findings are supported by previous studies where micromolar
concentrations of spiropyran derivatives were reported to have minimal cytotoxicity in macrophages,
gastric cells, and epithelial cells even after 72 h of exposure [48]. Sensor 1 is clearly cell permeable
and can detect intracellular GSH (Figure 8) with fluorescence intensity inversely proportional to
the concentration of GSH, as was observed in the solution-based experiments. The difference in
fluorescence intensity was observed for untreated and BSO-treated cells (~24%, Figure 9) is consistent
with a reported ~30% decrease in GSH levels in the presence of BSO [49]. This is an important finding
as it demonstrates the potential of sensor 1 to detect and quantify the decreases in intracellular GSH.
Future work is focused on using the sensor to examine intracellular levels of GSH in systems with
endogenously depleted glutathione such as cancer cells.
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4. Conclusions
In summary, we present, to the best of our knowledge, the first reversible ‘turn-off’ sensor 1 for
γ-Glutamyl-cysteinyl-glycine (GSH). Sensor 1 is unique in that it exists as the highly fluorescent MC
isomer in the aqueous environment. The addition of GSH results in a decrease in both the fluorescence
and the emission of sensor 1, indicating the formation of the SP isomer possibly through a reversible
conjugate addition and cyclisation sequence. 1-MC is regenerated on UV irradiation to enable multiple
cycles of GSH sensing. Sensor 1 is soluble in aqueous media and displays an excellent selectivity
for GSH over other biologically related analytes, importantly including other thiols. Sensor 1 can
detect changes of intracellular GSH in live HEK293 cells to provide a potentially regenerable sensor
for monitoring lower levels of intracellular GSH as associated with the onset of important diseases.
Future work will be focused on using the sensor to quantify GSH in degenerate human umbilical vein
endothelial cells (HUVEC) and in mouse oocyte, to advance our understanding of oxidative damage
in these cell types.
Supplementary Materials: The following are available online at http://www.mdpi.com/2079-6374/7/3/36/s1,
NMR spectra, Figure S1: Absorbance of sensor 6 (1 mM) in 2% DMSO in water (black) and acetonitrile (blue),
Figure S2: Fluorescence of Sensor 1 and 6, Figure S3: Quantum yield of sensor 1, Figure S4: Cytotoxicity of
Sensor 1.
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